Susceptibility of haemophilus influenzae to selected antimicrobial agents

Annals of Saudi Medicine

Volumn 16, Issue 5, 1996, Pages 582-586

  Kambal, Abdelmageed Mohammed ^a,b   Khaliq, Mohammad Raffique Abdul ^a   Chowdhury, Mohammed Nurul Haque ^a  

^a KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFACLOR; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; ERYTHROMYCIN; RIFAMPICIN; TETRACYCLINE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0029910983     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.1996.582     Document Type: Article

References (30)

1. Peltola H, Kilpi T, Anttila M. Rapid disappearance of Haemophilus influenzae type b meningitis after childhood immunisation with conjugate vaccines. Lancet 1992;340:592-4.
2. Powell M, Fah YS, Seymour A, Yuan M, Williams JD. Antimicrobial resistance in Haemophilus influenzae from England and Scotland in 1991. J Antimicrob Chemother 1992;29:547-54.
3. Doern GV, Jorgensen IH, Thornsberry C, et al. National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae. Antimicrob Agents Chemother 1988;32:180-5.
4. Campos J, Garcia-Tornel S, Gairi JM, Fabregues I. Multiply-resistant Haemophilus influenzae type b causing meningitis: comparative clinical and laboratory study. J Pediatrics 1986;108:897-902.
5. Machka K, Braveny I, Dabernat H, et al. Distribution and resistance patterns of Haemophilus influenzae: a European cooperative study. Eur J Clin Microbiol Infect Dis 1988;7:14-24.
6. Kayser FH, Morenzon G, Santanam P. The second European collaborative study on the frequency of antimicrobial resistance in Haemophilus influenzae. Eur J Clin Microbiol Infect Dis 1990;9:810-7.
7. Weinberg GA, Spitzer ED, Murry PR, et al. Antimicrobial susceptibility patterns of Haemophilus isolates from children in eleven developing nations. Bull WHO 1990;68:179-84.
8. Simasathien S, Duangmani D, Escheverria P. Haemophilus influenzae type b resistant to ampicillin and chloramphenicol in an orphanage in Thailand. Lancet 1980;2:1214-7.
9. Chugh TD, Neil L, Mahboob AG, Araj GF. In vitro activity of antibacterial agents on Haemophilus influenzae isolates. Trop Geogr Med 1986;38:404-7.
10. Chowdhury MNH, Mahgoub ES. Ampicillin-resistant Haemophilus influenzae in Riyadh, Saudi Arabia. Saudi Med J 1982;3:100-5.
11. Qadri SMH, Lee GC, Ellis ME. β-lactamase production in recent clinical isolates of Haemophilus influenzae and their susceptibility to cefaclor and other antimicrobial agents. Saudi Med J 1993;14:59-61.
12. El-Khizzi N. Antibiotics' susceptibility and biotypes of clinical isolates of Haemophilus influenzae. MSC dissertation, King Saud University College of Medicine, 1986.
13. Shibl AM, Gaillot O. Susceptibility of clinically significant Haemophilus influenzae strains to oral antimicrobial agents used in Saudi Arabia. Chemotherapy 1994;40:399-403.
14. National Committee for Clinical Laboratory Standards: methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically - 3rd edition; approved standards NCCLS document M7-A3 (ISBN 1-56238-209-8). NCCLS, Villanova, 1993:17-20.
15. Gutmann L, Williamson R, Collatz E, Acar JF. Mechanisms of βlactam resistance in Haemophilus influenzae. Eur J Clin Microbiol Infect Dis 1988;7:610-5.
16. Medeiros AA, O'Brien T. Ampicillin-resistant H. influenzae type b positing a TEM-type β-lactamase but little permeability barrier to ampicillin. Lancet 1975;1:716-8.
17. De Groot R, Campos J, Moseley SL, Smith AL. Molecular cloning and mechanism of trimethoprim resistance in H. influenzae. Antimicrobial Agents Chemother 1988;32:477-84.
18. Clymo AB, Harper IA. Ampicillin-resistant Haemophilus influenzae meningitis. Lancet 1974;1:453-4.
19. Khan W, Roos S, Rodriguez W, et al. Haemophilus influenzae type b resistant to ampicillin: a report of two cases. JAMA 1974;229:298-301.
20. Syriopoulou V, Scheifle D, Smith AL, et al. Increasing incidence of ampicillin resistance in Haemophilus influenzae. J Pediatr 1978;92:888-92.
21. Weinstein AJ. Worldwide epidemiology of Haemophilus influenzae. A worldwide pathogen (proceeding), Hong Kong: Science Press, 1987:9-12.
22. Howard AJ, Williams HM. The prevalence of antibiotic resistance in Haemophilus influenzae in Ireland. J Antimicrob Chemother 1989;24:963-71.
23. Hussey G, Hitchcock J, Hanslo D, et al. Serotypes and antimicrobial susceptibility of Haemophilus influenzae. J Antimicrob Chemother 1994;14:1031-6.
24. Gomez J, Ruiz G, Hernandez C, et al. Antibiotic resistance patterns of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a prospective study in Murcia, Spain, 1983-92. Chemotherapy 1994;40:299-303.
25. Bijlmer HA, van Alphen L, Greenwood BM, et al. Antibiotic susceptibility of invasive and noninvasive isolates of Haemophilus influenzae. J Antimicrob Chemother 1994;34:275-80.
26. Howard AJ, Williams HM. The prevalence of antibiotic resistance in Haemophilus influenzae in Wales. J Antimicrob Chemother 1988;21:251-60.
27. Markham A, Brogden RN. Cefixime: a review of its therapeutic efficacy in lower respiratory tract infection. Drugs 1995;49:1007-22.
28. Abraham V. The use of oral antibiotics in daily clinical practice. Drugs 1991;42(suppl4):1-5.
29. Doern GV. Resistance among problem respiratory pathogens in pediatrics. Pediatr Infect Dis J 1995;14:420-3.
30. Rizzato G, Montemurro L, Fraioli P, et al. Efficacy of three-day course in moderately severe community-acquired pneumonia. Eur Respir J 1995;8:398-402.